(RTTNews) – Dr. Reddy’s Laboratories Ltd. (RDY) and the Russian Direct Investment Fund (RDIF), the Russian sovereign fund, agreed to cooperate in clinical trials and distribution of the Sputnik V vaccine in India. India, RDIF will provide Dr. Reddy with one hundred million doses of the vaccine and deliveries can begin by the end of 2020.
The Sputnik V vaccine, developed through Gamaleya’s National Institute of Epidemiology and Microbiology Research, is the first vaccine recorded in the world opposed to COVID-19 on the human adenovir vector platform.
GV Prasad, Co-Chair and CEO of Dr. Reddy’s, said: “Phase I and II clinical trials have yielded promising results. We will conduct Phase III trials in India for the protection and efficacy of the Indian population and the needs of India. regulators. “
The Russian Direct Investment Fund (RDIF) is the Russian sovereign equity fund that allows co-investments in equities, mainly in Russia, along with renowned foreign strategic and monetary investors. The DRIF acts as a catalyst for direct investment in the Russian economy.